BANNSIDE PHARMACY LTD

Company Registration Number:
NI056112 (Northern Ireland)

Unaudited abridged accounts for the year ended 31 August 2024

Period of accounts

Start date: 01 September 2023

End date: 31 August 2024

BANNSIDE PHARMACY LTD

Contents of the Financial Statements

for the Period Ended 31 August 2024

Balance sheet
Notes

BANNSIDE PHARMACY LTD

Balance sheet

As at 31 August 2024


Notes

2024

2023


£

£
Fixed assets
Tangible assets: 3 265,374 272,448
Total fixed assets: 265,374 272,448
Current assets
Stocks: 77,600 72,700
Debtors:   71,599 79,717
Cash at bank and in hand: 174,869 144,524
Total current assets: 324,068 296,941
Creditors: amounts falling due within one year:   (226,704) (207,077)
Net current assets (liabilities): 97,364 89,864
Total assets less current liabilities: 362,738 362,312
Total net assets (liabilities): 362,738 362,312
Capital and reserves
Called up share capital: 2 2
Profit and loss account: 362,736 362,310
Shareholders funds: 362,738 362,312

The notes form part of these financial statements

BANNSIDE PHARMACY LTD

Balance sheet statements

For the year ending 31 August 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 19 November 2024
and signed on behalf of the board by:

Name: MR EOGHAN OBRIEN
Status: Director

The notes form part of these financial statements

BANNSIDE PHARMACY LTD

Notes to the Financial Statements

for the Period Ended 31 August 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

BANNSIDE PHARMACY LTD

Notes to the Financial Statements

for the Period Ended 31 August 2024

2. Employees

2024 2023
Average number of employees during the period 21 21

BANNSIDE PHARMACY LTD

Notes to the Financial Statements

for the Period Ended 31 August 2024

3. Tangible Assets

Total
Cost £
At 01 September 2023 450,104
Additions 4,187
At 31 August 2024 454,291
Depreciation
At 01 September 2023 177,656
Charge for year 11,261
At 31 August 2024 188,917
Net book value
At 31 August 2024 265,374
At 31 August 2023 272,448